Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women.
D Goodman-Gruen, D Kritz-Silverstein
https://pubmed.ncbi.nlm.nih.gov/11285326Completed
Phase 2
Age: 45Years - 74Years
FEMALE
ID00000613
Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2016-02-29
N/A
Participants Needed
N/A
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
To determine the acceptability and benefits of use of a dietary supplement of the phytoestrogen, genistein, versus placebo on heart disease risk factors, bone density, and psychosocial outcomes in postmenopausal women.
CONDITIONS
Official Title
CVD Risk and Health in Postmenopausal Phytoestrogen Users
Who Can Participate
Age: 45Years - 74Years
FEMALE
Eligibility Criteria
You may qualify if you...
Postmenopausal women, ages 45 to 74.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Trial Site Locations
Site Locations not provided
Location information for this trial is currently unavailable.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
N/A
Primary Purpose
PREVENTION
Number of Arms
0
Similar Trials
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Usual dietary isoflavone intake, bone mineral density, and bone metabolism in postmenopausal women.
Donna Kritz-Silverstein, Deborah L Goodman-Gruen
https://pubmed.ncbi.nlm.nih.gov/11860727Usual dietary isoflavone intake and body composition in postmenopausal women.
Deborah Goodman-Gruen, Donna Kritz-Silverstein
https://pubmed.ncbi.nlm.nih.gov/14501604